Bumrungrad Hospital Public Company Limited (BH) Earnings Call Transcript & Summary

Good morning. [Foreign Language]. Welcome to the Second Quarter Analyst Presentation for BHPCL. As is the usual case for this presentation format, we will begin with an overview by Neil Sorrentino, our Chief Global Strategist, in this quarter. Following that will be the financial presentation by Khun Jittima, our Deputy CFO. And following on that, a number of business updates, which will be presented by myself and Khun Wisut, our Chief Digital MarTech Officer. Without further ado, I would like to hand this over to Neil. Please?

[Foreign Language] Good day together. My name is Neil Sorrentino, Chief Global Strategist for the company. We welcome you to the Q2 2021 takeaways for Bumrungrad Public Company Limited. For the quarter, we're going to take a little bit different tact for the Q2 presentation. I've asked our staff to give a much deeper dive into the composition of the data that is driving our revenue. As you have seen already, the quarter was a significantly stronger quarter than Q1 2021 and, of course, much stronger than Q2 2020 because that was the peak of the beginning of the COVID impact all over Thailand. The theme for us over the last really 15 months has been agility, rotation of the business and the compositional change of that business, as we moved away from international, because borders were closed for the most part, and focused on Thai business, expat business and some international business that we did experience in Q2 on an emergency medical treatment basis, which generates revenue in a particular category called Alternative Hospital Quarantine. And we'll talk more about that in a moment. But you're going to be able to see this quarter how it is that we're generating this kind of revenue just essentially looking at business in Thailand. So let's talk about the top line key takeaways of the quarter. For the quarter, the quarter-over-quarter revenue was 12.8%. There was very, very strong support both from COVID revenues amongst Thai people, expats. And you will see, when I go through this, the additional level of detail, which amounted to about a 25% increase of Alternative Hospital Quarantine patients. And these were real patients that came in internationally. But as you know now, in Q3 forward, the borders are completely shut. So there's no one bringing in any international patients, and that includes us. The presenters today, especially Daniel and Khun Wisut, our Digital Marketing Officer, are going to go through the level of details that drove this 12.8% revenue increase. And just on the Thai business alone, the amount of additional incremental revenue Q-over-Q was THB 171 million, and that came from a variety of different programs, not only COVID treatments and COVID screenings, but also came from online and offline digital platforms. In addition, we launched our own version digitally of Moderna vaccine program rollout, for which, in the end, we purchased -- an advanced purchase, an advanced payment a little over 17,000 jab vaccinations, which we'll be receiving in the middle of Q4 sometime, as we are told by the Government Pharmaceutical Office, which is a sub-entity of the government. That entire allotment is sold out in advance, and we'll administer that in Q4 and rolling into Q1 2022. So let's get into some level of the detail on the business for Q2. For the overall market, I've mentioned 12.8% quarter-over-quarter, while not meaningful, in terms of the comparative nonetheless from Q2 2020, the growth was quite significant, but not of use in terms of comparing, because they're really not comparable. Next slide. So then now if you look deeper into the Thai revenue, you can see the chart below. But you can see for the Thai, revenue had increased quarter-over-quarter 12.1%. And when you look at the numbers inside that percentages from COVID business, meaning screenings, meaning treatments, the amount of revenue generated was an incremental THB 95 million. The amount of online revenues increased by THB 23 million. Increase in our telemedicine services was THB 20 million. And then others was about THB 34 million. And Daniel later is going to talk about that level of detail. Next slide. Similar story for expats. The growth for Q2 was up 7.2%. Again, on the quarter, a pretty significant growth and, of course, a significant growth over 2020. When you look deeper into what the 7.2% entailed, it was about THB 34 million, again, related to COVID screenings and treatments; online revenues, almost THB 9 million; and then all others made up the difference. When you look at the nationality, so when you think about expat for us, there's 2 types of nationalities. You have all those except Middle Eastern nationalities, and then you have all other. So for us, all other in the quarter, we saw significant growth, and Bangladesh was up 11%; Germany -- these are by nationality, Germany up 9.7%; Japan up 9.5%; the United States up 9.3%. When you look at the net revenue growth, Japan was #1 at almost 30% growth quarter-over-quarter for -- I'm talking about '20 versus '21; Australia almost 17%; India 13%, et cetera, et cetera. So we had strong broad year-over-year growth, of course, but very strong quarter-over-quarter growth. And you can see the monthly performance, the green line versus the dark line. Next slide. So this is all international. So this is everything that we define all international, which includes all of it. And the growth was almost 19% quarter-over-quarter. Recall now that this includes AHQ revenue that was fairly substantial in the quarter because it was still allowing emergency international patients in. And this is, as an example, Indochinese and others, and we show that detail. Next slide. So when you look at what drove some of those numbers on the growth percentage, you can see by nationality and country Kuwait, Qatar, Myanmar, Mongolia. And the first 3, while these are percentages, when you look at the revenue behind them, they were fairly substantial. I mean we still maintain a fairly good volume of business from Middle Eastern patients, those that have been here and a few that do trickle in. And then the rest, you can see the distribution. Bangladesh was pretty strong in the quarter, Bahrain, Oman. But on the larger volume-related revenue, the top 3 were the most significant contributors on revenue, especially Q-over-Q and, in some cases, year-over-year for the quarter. So total international was up almost 19% for the quarter. Again, when you look at the distribution of contribution of the revenue drivers, this was an important one for us, too, beyond Thai, beyond expat. Next slide. Middle East, again, another major contributor to our revenue base quarter-over-quarter, almost up 25%. Against Q2 '20, it's going to be less because the borders at some portion of Q2 '20 -- 2Q '20, there was more of a free flow beginning to starting to close down. But against Q1, it was substantially higher because we were able to bring in patients who were quite ill and approved by the Ministry of Public Health. Next slide. Indochina, very much a similar story, strong uptick in revenue over quarter, 28.3% from Q1. And the year-over-year change was very, very high because by that time, Myanmar was just about shut, although there are other parts of Indochina, Cambodia, Laos, et cetera. And I'll show you that. Next slide. So on a consolidated basis, when you look at AHQ and ASQ performance for the quarter, you will see that for the AHQ THB 536 million for Q2; THB 428 million for Q1 of 2021, and that represented about 25%. More importantly, when you look over to the right, you'll see a conversion of 67%. And as I've explained in the past, there is revenue generated that is associated with being in the AHQ, which means quarantine for 10 to 14 days depending. And there's some revenue generated there, but the 67% has to do with, in addition, revenue that is generated by those patients who then use our inpatient and outpatient facilities. In a similar way, although more transitionary, you have the ASQ where the conversion rate for the quarter was 16%. In Q1, it was only 10%. So that rose as well for the quarter for us. All of the indices on revenue drivers, on market drivers, on digital platform drivers were all striking a very, very positive ability to drive revenue in the quarter and, as a result, drove us up to almost 13% quarter-over-quarter performance. Okay. Please go back to the highlights. So as we look at expectations going forward, the latest information that we hear and see through governmental agencies, through government-sponsored organizations, through commercial banking expectations, specifically Bank of Thailand and Tourist (sic) [ Tourism ] Authority of Thailand, they are guiding that given the huge surge in COVID patients, meaning infections, case rates, infection rates, death rates, given the current rising orientation. And just today, we saw that there was a record high, over 22,000 infections yesterday in Thailand. A reasonably good portion of them in the greater Bangkok area and provinces surrounding Bangkok. There is a high level of uncertainty, low consumer confidence, high savings as a result of people not wanting to spend money, wanting to [indiscernible] money because unsure where this is all going. So for us, when we look at what used to be the biggest portion of our business, which was international, we're really not expecting that to return to any level of normal performance until sometime in 2022. When that is in 2022 will really depend upon the government vaccination program and the availability of additional vaccines being brought into the country, which, as you know, media has reported that it's been slow in coming into the country and also slow in its distribution. But many of the experts expect that to change and get better as we move into Q4 and beyond. But that's a major limiter to how it is that the country will open up. Firstly, the sandboxes, both in Phuket, although it has opened up, it's been slow. Samui is just about to open up, but slow. Need to bend that curve downward in the number of infections in order to create stronger consumer confidence. But in the meantime, we as a company recognize this because we're looking around the world and looking at surges and watching how it is that these surges continue growing upward with higher and higher infection rates and then declining. As the curve was bent downward, we anticipated that we'd have to focus on the business at hand, which is what we have in Thailand. And now even in the third quarter, with the borders now shut, we even have to be more reliant on the business here in Thailand. And we're prepared to do that. I think Q2 showed you, as investors and interested people in our company, that we've been quite successful at doing that. At our Board meeting this past week, our Board of Directors looked at the different possibilities and variations on the interim dividend payment. And it being a strong value company with strong cash reserves, the Board on Wednesday evening approved a dividend payout on EPS of about 300% of EPS. And the amount is a little over THB 900 million, and that will be paid in the early part of September to shareholders of record. A strong commitment once again to our shareholders owning shares in our company. As of the end of July, the company was in a very strong position, having THB 8.3 billion in cash. And of course, those who follow us know we're in a negative debt situation. For Q3 guidance, with almost 13% growth in top line revenue, it's uncertain about where we will be in Q3 and Q4, strictly predictable and driven by the number of infections, the rate of the lockdown, the extent of the lockdown, the duration of the lockdown, but we will continue to execute through our offline and digital platform to drive supplemental revenue for those people that are concerned about coming into the campus. And of course, there'll be revenue driven by -- unfortunately, at least at this point in time, will be driven by COVID screenings, COVID treatment and vaccinations, which we're very, very much focused on, which you'll hear a great deal more about how we're driving our orientation as we look at our business composition having been different really over the last 2 to 3 quarters. Thank you.

[Foreign Language] Good morning, everyone. I'm, Jittima Nuntavichithaporn, Deputy CFO. I am pleased to report the financial performance of the second quarter 2021 and the first half of 2021. First, financial highlights. Despite the surge in COVID-19 cases in Thailand in mid-December 2020 and continuing into 2021, the Thai and expat business continued to grow year-on-year. Restrictions on travel and medical tourism continue to impact the company international business, especially when compared to the first high base of the first half of the first quarter of the previous year when COVID-19 was only marginally impacting the company's performance. The second quarter of 2021, revenue increased by 23.2% year-on-year. This was mostly due to an increase in revenue from Thai patients by 27.2% and non-Thai patients by 18.5%. EBITDA increased by 81.7% with EBITDA margin of 19.1%, increase from 12.9% in the second quarter of the previous year. Net profit and diluted EPS increased significantly by 387.2%, with a net profit margin of 7.2% compared to 1.8% in the second quarter of the 2020. The second quarter 2021 performance improved from the first quarter 2021, primarily due to the increase in revenue from Thai, expat and international patients from Alternative Hospital Quarantine service. Revenue increased by 12.7% from Q1. And net profit grew by 137.5%. For the first half 2021, revenue decreased by 13.5% from the previous year, EBITDA down by 36.6% with EBITDA margin of 17.3% compared to 23.6% in the first half of 2020. Net profit decreased by 52% with net profit margin at 5.4% in the first half of 2021 compared to 12.3% in the first half of 2020. The decrease mostly attributed to the limited impact of COVID-19 during the first quarter of 2020. Move on to financial performance. The company reported total revenue in the second quarter of 2021 of THB 3,020 million. This amount represented a 23.2% increase from the second quarter of last year. For the first half of this year, total revenue was THB 5,694 million, a 13.5% decrease year-over-year. This was mostly due to a decrease in revenue from non-Thai patients by 32.3%, offset with an increase from Thai patients by 13.1%. Revenue contribution by nationality. As restrictions on travel and medical tourism continued to impact the company's international business and our continued marketing for local markets, the percentage of revenue from Thai patients increased to 54% for both second quarter and the first half of 2021 compared to 52% in the first quarter of 2021 and 41% in the first half of 2020. Revenue contribution by services. For the second quarter of 2021 and 2020, the proportion of revenue from inpatient services and outpatient services was the same at 52% and 46%. For the first half of 2021, the proportion of revenue from inpatient services slightly decreased from 54% to 53%, mostly due to a slight decrease in average length of stay for non-Thai segment. Revenue contribution by payor type. There was a shift in payor mix due to COVID-19 pandemic impact. The government third-party payor contribution was reduced from 19% last year to 11% for the first half of this year due to restrictions on travel and medical tourism for Middle East business. Self-pay also was increased from 60% to 64% in the first half of this year, mostly due to an increase in Thai and expat self-pay. Insurance contribution also increased from 19% to 22% in the first half of 2021 due to an increase in Thai and expat insurance business. EBITDA was THB 576 million in the second quarter of 2021, increase by 81.7% from THB 317 million in the second quarter of 2020. The increase was mostly due to the increase in revenue and also our cost management programs related to workforce management, contract management and inventory management. EBITDA for the first half of 2021 was THB 986 million, a 36.6% decreased from THB 1,555 million in the first quarter of last year. The decrease was mostly attributed to the limited impact of COVID-19 during the first half of 2020. EBITDA margin was 19.1% in the second quarter of 2021, increase from 12.9% in the second quarter of last year. EBITDA margin was 17.3% for the first half of 2020, decrease from 23.6% in the first half of last year. Net profit for the second quarter of 2020 was THB 216 million, increase by 387.2% from THB 44 million in the second quarter of the previous year. Net profit for the first half of this year was THB 308 million, a 62% decreased from THB 810 million in the first half of 2020. Net profit margin was 7.2% in the second quarter of 2021 compared to 1.8% in the second quarter of 2020. For the first half of 2021, net profit margin was 5.4% compared to 12.3% in the first half of last year. Net debt to EBITDA was 0.6x for the first half of 2021, slightly higher than year 2020 due to less EBITDA in the first half of this year. Net debt to equity was 0.1x as of June 2021, almost the same as December 2020. Interest coverage ratio was dropped to 15.1x due to less EBITDA. However, when considering bond covenant requirement, which require to have net debt to EBITDA at less than 3.25x and net debt to EBITDA at less than 1.7x, the current net debt to EBITDA and net debt to equity for the first half of 2021 is still a lot lower than the bond covenant requirement. Thank you.

Thank you, Khun Jittima. I'd like to start off with the business updates with the Q2 2021 snippets. This is essentially a new way for us to present some key numbers during the quarter, which we believe would be of interest to you. Let's start off with the first item. You may notice that under The1 Card direct accretive revenue, this is essentially revenue generated directly incrementally from new and existing reactivated patients. And what we mean by that is reactivated patients being people who have visited the -- who have not visited the hospital over the last 2 years, having once again used services at Bumrungrad, BHPCL. The1 Card is essentially a partnership loyalty program between Central Group and ourselves, and it has proven to be very successful in driving additional spending and incremental revenue to the hospital. We calculate approximately THB 291 million in revenue generated in the second quarter 2021, which is a growth of 27% Q-on-Q or 2,930% year-on-year. And the reason for that large growth number is from the -- is due to the start of the program in May of last year. So due to that, the low base effect, you need to take into account as well. The other channel, which was significant during the quarter were referrals from other hospitals, generating approximately THB 211 million in revenue. Referral from other hospitals include hospitals that are under the Bumrungrad Health Network and from other local hospitals within Thailand who have referred either complicated cases or overflows to Bumrungrad Hospital itself. This number continued to grow and has continued that trend over the last several quarters already, generating 39% Q-on-Q in growth and 21% year-on-year in growth. Something that many people would be interested to know is COVID-19 revenue. So revenue generated from COVID-related treatments and screenings amounted to approximately THB 198 million during the quarter, a growth of 321% Q-on-Q or 372% year-on-year. The growth has been significant and is in direct proportion to the number of new COVID cases that we are currently seeing during the third wave, which continues still unabated since May. On to telemedicine and home care revenues, that amounted to THB 115 million during the quarter and continued to grow quite strongly, up 31% Q-on-Q, 11% year-on-year. The telemedicine and home care services has grown quite well, given the reluctance of people to seek health care on-premise at the hospital. We have, therefore, digitally engaged with the patient through telemedicine and home care services, and that demand continues strongly. On online store and digital products, these are essentially products we sell on our online store, both in the website and through the Bumrungrad app. These include packages such as screenings and other ancillary products, which we are selling online and digitally. These products have shown remarkable growth, 618% Q-on-Q or over 1,000 -- sorry, over 103% year-on-year. The online store is a relatively new development, which only began to take root since the beginning of last year. And we've been very proud and pleased with the uptake of this channel in driving revenue growth to the hospital. On to the COVID-19 vaccination program, the hospital has received very good feedback from patients who have received vaccinations, both government provided and also privately funded vaccines such as Moderna. We've also begun to organize inoculations for the Pfizer vaccines that have been received, thanks to the generosity of the U.S. government for health care and frontline medical care workers. Some of these have been also allocated to expats, and we have also begun to organize bookings for expats as well. I'd like to show you a clip on the vaccination, and these have been designed specifically for Japanese expats. [Presentation]

In addition to providing vaccinations, we have also opened the opportunity for patients to buy checkup packages under the very popular buy 1 get 1 free campaign. This was again reinitiated during the June, July period to sell packages to people coming for vaccinations. And as you can see, it generated approximately THB 19.5 million in additional revenue for the hospital amounting to 801 packages. During the quarter, we also launched 2 key clinics, the Pride Clinic, essentially providing transgender or sexual reorientation services to patients seeking those services. These are rather extensive, not only surgical, but includes multidisciplinary approaches to treating and preparing patients for these kinds of surgical procedures, hormone therapy and other areas, which we hope to continue to expand. The market is significant, not only within Thailand, but also targeting international patients, specifically in China, where we see a large number -- where we see high demand from patients. And we expect that once the country opens up, we can tap into this high-growth area. Secondly, the Allergy Clinic, which we have already established, but we have enhanced with services related to home care and treatments. These are just a few slides of the launch of the Pride Clinic, which was very well received by the public. On to our target and how we expect to continue growing our business. As you may know, the international market continues to be relatively closed to receiving -- relatively closed in terms of its -- in terms of the continued travel restrictions that we have in Thailand. So our focus continues to be on the Thai and expat segment. And what are we doing in growing that area? We're looking at expanding our digital connections with our patients through social media, through content and growing awareness and demand for health care related issues. We are observant of the fact that throughout the world, due to people's reluctance to come to hospitals, a number of underlying health issues will start to take increasing prominence in terms of their effects on people's health due to the lack of health screenings, due to a lack of follow-ups with physicians, et cetera, and also the lack of activity at people's homes. And as a result, we continue to want to engage with our patients in highlighting underlying health issues that may continue to affect them during this time of the lockup. On to the expat market. As you can see, we've targeted 4 key categories of expats: the Japanese expat market, the American expat market, the Chinese expat market and the Indian expat market. All 4 have specific key focuses. As you can see on these slides, for Japanese, OB-GYN, sports and joint; on Chinese, oncology and also IVF as is well known to be in high demand. For the Indian market, which is significant in Thailand, oncology and colorectal are key areas of focus. And for American expats in general, OB-GYN and also oncology as well have been key focuses for us. These are areas of significant strength for us, and we expect to continue to utilize these to further penetrate those markets. And as you will see -- as you have seen, the growth in the expat market has been rather encouraging during the quarter and has continued to be the case since the previous quarters as well. So that concludes my part of the business update. The next part will be presented by Khun Wisut, our Chief Digital MarTech Officer, who will provide us with exciting updates on what we are doing in this area. Khun Wisut, please?

Hi, everyone. I am Wisut Ua-anant, Chief Digital MarTech Officer at Bumrungrad. Today, I would like to update you about the MarTech work for Q2. First one about our BH online store, it is the second year of the online store that we did. And currently, we have more than 349 package sale that come from 42 clinics in online store. We still have more clinic in Bumrungrad, we have more than 60 clinics. We can add more in the future. The approach that we did for the online store is totally different from the competitor. We use the approach that call direct-to-consumer approach. What it means for this? The direct approach -- direct-to-consumer approach is mean all the data is collected by us. And this year, I used the data from last year to retargeting the customer for this year. And also, we have all the 360 view of the behavior of customers that we can find the package more and look alike model to find more customers to buy as well. It's totally different from the competitor that use [indiscernible] to sell package. That way, it means all the data belong to that platform. They cannot do like us. That's why they have to use the platform from [indiscernible]. And we did our update in-house development in Bumrungrad for the holding. Okay, let me continue. Clearly, we already have the vaccine store [indiscernible] example. We have vaccine store. We have women's center. We have children's center and have specifically for each clinic and each package for the customer. And we also have the nutrition and also teleconsultant for nutrition package in here. And this one genetic store. Genetic store is the new store that we also did the new promotion with [indiscernible] can redeem the pie and use the pie to convert to be the discount code to get genetic for free. Currently, our online store support for exchange the pie, exchange the discount code with the partner. Okay. This one is the revenue. This one, last year, online store we ran for the first year, we got THB 36 million in 36 days on that time, when we have the buy 1 get 1 campaign. For this year, you can see April and May, there's growth because we have buy 1 get 1 campaign on that period. For June and July, we do not have the buy 1 get 1, but we still can maintain the revenue growth. After that, I will show you what is the reason we can make it grow. But this year, we can make THB 65 million in 45 days. It's more than 100% from last year. And we also made the overall for our online store until July. It's more than THB 100 million already. This one, we achieved more 100% up the total year last year. Okay. This is the new feature that we did on July. We integrate with The1 Point -- from The1 Point to convert to be the redemption discount for the online store. And people also earn the payment that they have in here to be the point of The1 as well. We already made this one happen in online. And okay, this one is the one that incredible thing for me. I did in online stores in many companies, but I never see that I can say THB 500,000 gift card. But I can make this thing happen in Bumrungrad right now, and we sell the best-selling as well on for this one. This one, that's why we can maintain the revenue growth from the gift card THB 500,000. And we offer right now people by THB 500,000, they can get THB 25,000 increase for -- they purchase more. Totally for the revenue clearly is more than THB 63 million from gift card. And you can see for the THB 500,000 value just only 1 month, we can sell 37 package in 1 month. We just run this in July. And for the -- you can see the online, offline part. Online is the THB 49 million and offline is THB 13 million. Offline, this means we have -- we also have the physical gift card that sell in offline. And people can come to here to buy the physical gift card and give it to the patient in the IPD room, something like that. We did -- this concept is the new innovation concept that we are the first in Asia in hospital that we have the gift card to send the [ new normal way ] to visit the patient. We can send via live as well clearly. And we also send via e-mail. [indiscernible] that we can send right now. Okay. For application, BH application, currently, we have 58,000 people that actively use our app right now. You can see we have incredible growth. In 1 day, we can grow more than the whole year, because we did the my vaccination record that people can check about the vaccine, what is the first injection, the second injection, something like that. And people have to link the [indiscernible] to see their own patient information. You can see we have the Android and iPhone. And Bumrungrad iPhone more than Android. It's 70% and 30% is about Android. Okay, the next one. The next one, I update you about the feature of that application. We have the new feature, 6 feature and have offers and voucher. Okay. I will show you how it is. Actually this is indicated with the online store. When you purchase anything voucher from online store, it will automatically link the voucher to the application. You just come to here and open the application, you can scan the barcode and treatment layaway. After your treatment, you can go back home. No need to go to cashier anymore because you already paid for the online store. And we also have the birthday discount code 10%. This one, we offer -- we use the database of the Bumrungrad. And [indiscernible] we will have the people who birthed on that month, we offer 10% discount for them in the online store. But they need to use application only to get this voucher to endorse them to use our application more. And we can retargeting them. And my vaccination record, the third one is the new feature that we did and really success and people load our app more and more and use every day. And they're going to keep this information for the whole life. Because if you want to know your first injection of vaccine, second injection of vaccine and other vaccine, you need to click on this menu. And also, we can offer the additional vaccine in the future to -- via this menu as well. Okay? The fourth one is about recommendation package. I will show you how it is. And fifth is about keyword suggestion for doctor search. Right now, we make the better search for doctor. You can search in speciality, last name, first name. You can search [indiscernible], you can search symptom, condition, treatment, other things. And the last one is the online official account. Thailand used the -- the second in the world to use live. That's why we support live chat with our application as well. Okay. Let's see detail. The first one is about offer and voucher. This one integrated with the BH online store partner. Where people buy anything from online store, the history of purchase will go inside the application. In application, we will have status to tell that it actually is used, is expired to remind the customer as well. And we also have the birthday campaign in here. On your birthday -- birth month, right, you're going to get this voucher and it's going to remind you to use to discount the 10%. Okay. The second part -- this one is about the voucher, the history of voucher and the status of voucher, any voucher that you purchase. You can use the barcode to scan in hospital and treatment layaway. And it also has the share icon. Right now, we make any purchase of the voucher, you can make it share to anyone you love. You can share to your family, your friend. You can share to anyone [indiscernible] because it's similar to the bank account. When you transfer a bank account, you can send the picture of the transfer to the phone, right? You can forward that picture to anyone you love. But this barcode can use only one time in here. It's a new way to make every voucher as a gift. Okay. This one is the highlight one for the application this year. It's my vaccination record. You can see that are people concerned about [indiscernible] and concerned about the date to inject the vaccine, the first shot, the second shot, right, maybe the third shot or fourth shot. We already made this thing happen for the Bumrungrad. And you can see it not shows only the COVID vaccine, it shows every vaccine that you inject in Bumrungrad. And you have the date and time to tell you. In the future, it can make like a passport for you that you already have, which vaccine you already have. You can see all the vaccine that you have in Bumrungrad is automatically shown in here. Okay. For this one, it's about the keyword suggestion for doctor search. You can search the doctor name, last name, speciality, subspeciality, symptom, disease and keyword. It will suggest and you can find a doctor easier, and you can click on the doctor. Clearly, you can make appointment. In the future, you can make telemed appointment as well. Okay. Next one is online integration. For the ask question in the application, we have live, we have Facebook Messenger, Whatsapp. And we can make call. We can make appointment into the application. We also support live and we can now support all the chat, that support for each country, because we decide this application not only for Thai, but we decide for the global. Okay. This is the new feature that's going to happen on the 26th of August. We will have the BKI free insurance for COVID vaccine. We can have the Japanese language support. We will have the podcast section. We will have the dynamic appointment confirmation. And we will have the telemedicine integration. The first one, BKI. This one, anyone who is going to come to Bumrungrad and inject the COVID vaccine, you can come to our app and click on the BKI and fill the form. You're going to get a free protection for the vaccine. If you have some effect with the vaccine, BKI will support you. This one is going to happen on 23rd of August. And this one is the Japanese version. We support Japanese people because we've got the vaccine from embassy -- Japanese embassy to come to inject to Bumrungrad. And we want them to have the version of Japanese to help them and vaccination record to help the Japanese people as well. Clearly, we have English, Thai and Japanese. We will have the Chinese and Arabic soon. It means we're going to support almost all the target customers that we have in Bumrungrad. Okay. For podcast, if anyone had the AirPlay or the Google Play, Google car, you can link the application BH app with that. It means that you can when you drive the car, you can listen the podcast of the Bumrungrad in car. We have this section up for the 23 August as well. This one is the feature of telemedicine integration. We already have the telemedicine for follow-up clearly. And we will have the appointment reminder. We will have the telemedicine reminder in here. And people can click on the application to talk with a doctor right away. This is the old version of our telemed. We will have the new telemed on-demand. It is going to happen in next month. This one is about e-payment system. This is the new enhancement of e-payment we launched on the 16th June. Currently, people don't want to come to hospitals because they worry about the COVID. We have the way to send the e-payment link to them anywhere in the world. And they can click the link to make payment for family, for yourself or for anyone. We have many options. Currently, we did our own payment system. And we can open and we can turn on and off for any payment gateway in here. We not do only one payment gateway, we're going to do for medical payment gateway in here. And you can see we will have PayPal, we have Amex coming soon. We also did the payment gateway from Asia and have the growth tourism for the whole Singaporean, other things we already integrated in our e-payment system as well. This one already support for future. Okay. This one is about the way you chat to the contact center. And we also add the chat to the expert, chat with nurse and through the clinic specifically. We can have the landing page, specifically for heart, for any specific clinic and people can click to consult with the expert and chat directly to the nurse with our new system. And we built AI on top to become like a chatbot to try to find a FAQ, frequently asked question first. And if that one cannot answer, it moves forward to the right people. And it's also linked to the CRM case management part. In that, we have SLA to answer the customer. This feature also available for any chat of the Bumrungrad and also on the BH Application. Okay. We already rolled out with the COVID central team, information team. If anyone had the question about the vaccine, about the COVID, they can come to our chat and ask. And we have the mascot to be the chatbot currently. Okay. This is the look and feel chatbot in the app. It's just on version 1. Actually, we already prepared -- our chatbot already supports Thai, English and Chinese. We're going to make it support for Japanese and Arabic later. Okay. That's all from me. Thank you.

Thank you, Khun Wisut. And that concludes our second quarter 2021 analyst presentation. Stay tuned for the live Q&A session. For those who are invited on the 19th of August, we will be posting this presentation to you on the 17th of August. So you'll have plenty of time to review and ask us any questions you may have. As usual, you can always contact us through all the regular channels. Thank you.